Clinical outcomes for cystic fibrosis patients with Pseudomonas aeruginosa cross-infections.
Justyna MilczewskaTomasz WołkowiczKatarzyna ZacharczukEwa MierzejewskaMonika KwiatkowskaKatarzyna Walicka-SerzyskoDorota SandsPublished in: Pediatric pulmonology (2019)
Cross-infections with P. aeruginosa occurred in our group of patients and were associated with poor clinical outcomes. Antimicrobial resistance rate in the strains isolated from such infections was significantly higher, and this included three strains resistant to colistin.
Keyphrases
- pseudomonas aeruginosa
- cystic fibrosis
- antimicrobial resistance
- escherichia coli
- end stage renal disease
- newly diagnosed
- ejection fraction
- acinetobacter baumannii
- biofilm formation
- chronic kidney disease
- peritoneal dialysis
- klebsiella pneumoniae
- patient reported outcomes
- chronic obstructive pulmonary disease
- staphylococcus aureus
- gram negative